DCDC2 p.Pro152Ala
c.454C>G · rs33914824 · VCV466326
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1332 | likely benign |
|---|---|---|
| REVEL | 0.441 | indeterminate |
| SaProt | LLR -10.93 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · G>A here scores Δ0.20 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 12 | GERP 1.8, phastCons 1 |
| Regional constraint | o/e 0.98 | unconstrained · MANE · 183 kb · p 0.62 · regional, not allelic |
| Overall | ||
| CADD | 25.9 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Amishnot grpmax-eligible | 9.56% | 10 |
| Ashkenazi Jewishnot grpmax-eligible | 5.8% | 17 |
| South Asiangrpmax | 5.33% | 19 |
| Middle Eastern | 5.31% | 19 |
| Remaining individualsnot grpmax-eligible | 4.27% | 23 |
| African / African-American | 4.13% | 24 |
| European (non-Finnish) | 3.98% | 25 |
| Admixed American | 2.8% | 36 |
| Finnishnot grpmax-eligible | 1.7% | 59 |
| East Asian | 1.66% | 60 |
Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DCDC2
- Protein
- p.Pro152Ala
- Coding
- c.454C>G
- MANE Select
- NM_016356
- dbSNP
- rs33914824
- Type
- single nucleotide variant
- Location
- chr6:24301818 (GRCh38)
- Gene constraint
- LOEUF 1.062 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 63.93 · 1 PDB
- Residue 152
- a UniProt-annotated variant site (in); the doublecortin 2 domain
Disease context
isolated neonatal sclerosing cholangitis — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: autosomal recessive nonsyndromic hearing loss 66
For Isolated neonatal sclerosing cholangitis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Neonatal
Similar variants
- DCDC2 p.Pro152= Likely benign ★ same residue
- DCDC2 c.294-2A>G Pathogenic ★★ same condition
- DCDC2 c.349-2A>G Pathogenic ★★ same condition
- DCDC2 c.705-2A>G Pathogenic ★★ same condition
- DCDC2 p.Leu297Ter Pathogenic ★★ same condition
- DCDC2 p.Met1Arg Pathogenic/Likely pathogenic ★★ ⚠ same condition
- DCDC2 p.Ser128Ter Pathogenic/Likely pathogenic ★★ same condition
- DCDC2 p.Ala384Gly Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dcdc2-p-pro152ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown